Evidence map›Paper›PMID 27829273›Full record

ArticleBiointerphases2016

Multitechnique characterization of oligo(ethylene glycol) functionalized gold nanoparticles.

Ali Rafati, Alexander G Shard, David G Castner

Abstract read
In one paragraph

Article in Biointerphases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali RafatiNational ESCA and Surface Analysis Center for Biomedical Problems, Departments of Chemical Engineering and Bioengineering, University of Washington, Box 351653, Seattle, Washington 98195-1653.
Alexander G ShardNational Physical Laboratory, Teddington, Middlesex TW11 0LW, United Kingdom.
David G CastnerNational ESCA and Surface Analysis Center for Biomedical Problems, Departments of Chemical Engineering and Bioengineering, University of Washington, Box 351653, Seattle, Washington 98195-1653.

Funding

Surface Analysis Facility for Biomedical ProblemsP41EB002027 · NIBIB · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G, GAMBLE, LARA · 2003 to 2019
$17.6M
NIBIB NIH HHS P41 EB002027
6 · The paper itself

Abstract

Gold nanoparticles (AuNPs) with average diameters of ∼14 and ∼40 nm, as well as flat gold coated silicon wafers, were functionalized with oligo ethylene glycol (OEG) terminated 1-undecanethiol (HS-CH

Indexed as

Chemical PhenomenaEthylene GlycolGoldMicroscopy, Electron, TransmissionNanoparticlesParticle SizePhotoelectron SpectroscopyScattering, RadiationSpectrometry, Mass, Secondary IonSpectroscopy, Fourier Transform InfraredEthylene GlycolGold

Identifiers

PMID27829273
PMCPMC5106433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.